| Expression pattern: |
DN |
| Associated gene: |
CASP8, CCND1, CYCS |
| Associated microRNA: |
hsa-miR-150, hsa-miR-34a, hsa-miR-494, hsa-miR-182 |
| Biological function: |
Potential tumor-suppressive role in RCC; downregulation may increase RCC metastasis; proposed involvement in ceRNA-mediated regulation of hub genes. |
| Molecular mechanism: |
Predicted ceRNA mechanism involving sponging of hsa-miR-150, hsa-miR-34a, hsa-miR-494 and hsa-miR-182 to regulate CASP8, CCND1 and CYCS. |
| Biological pathway or process: |
ceRNA regulation (other); metastasis (inhibits); apoptosis (other); cell cycle (other) |
| Detected method: |
Q
|
| Validation methods: |
Back-Splice Junction PCR / divergent primers PCR; RT-qPCR; Clinical Sample Validation; Bioinformatics Analysis |
| Clinical significance: |
hsa_circ_0020397 had significantly lower expression in RCC patients with a history of kidney disease. |
| Description: |
hsa_circ_0020397 was significantly downregulated in RCC tissues and in ccRCC samples. The study predicts that it may act as a ceRNA in RCC, particularly through hsa-miR-150/CASP8 and hsa-miR-34a/CYCS-related axes, and its downregulation may contribute to RCC metastasis. |
| Confidence score: |
0.4685 |